News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Teatime with SHE featuring Zainab Shinkafi-Bagudu and Navid Madani
Zainab Shinkafi-Bagudu/LinkedIn
Mar 11, 2025, 07:33

Teatime with SHE featuring Zainab Shinkafi-Bagudu and Navid Madani

Zainab Shinkafi-Bagudu, UICC President-Elect of 2024-2026, shared a post on LinkedIn:

“Join us at the Dana-Farber Cancer Institute SHE Center for an inspiring conversation where I will be interviewed by Navid Madani.

Today at 2 PM EST. Don’t miss this insightful discussion!

Register.”

More posts featuring Zainab Shinkafi-Bagudu.

cancer Dana-Farber Cancer Institute OncoDaily Oncology SHE Center Teatime with SHE Zainab Shinkafi-Bagudu
Special Coverage
Blog
May 16, 2025, 13:31
Anju Aledia: Exploring Science up Close with a Magnifying Glass
Blog
May 16, 2025, 13:24
Amil Družić: The European School of Oncology's Improving Cancer Outcomes and Leadership Course in Zagreb
Oncolibrary
May 16, 2025, 13:21
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
Blog
May 16, 2025, 13:01
How Countries are Engaging Stakeholders in the Development and Implementation of NCCPs - Union for International Cancer Control
Oncolibrary
May 16, 2025, 12:59
Eating Well with Mesothelioma: What You Need to Know
Blog
May 16, 2025, 12:54
Douglas Flora: Fantastic Day Connecting with the Incredible Leaders at St. Elizabeth Healthcare
Blog
May 16, 2025, 12:37
Impact of Research Through Maggie’s Lung Cancer Journey - LUNGevity Foundation
Blog
May 16, 2025, 12:28
Giulio Draetta: A $150 million Gift from Kinder Foundation
Science
May 16, 2025, 12:19
Environmental Risk Factors of Wilms Tumour - Childhood Cancer and Leukemia International Consortium
Science
May 16, 2025, 12:17
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025
Oncolibrary
May 16, 2025, 11:45
DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer
Blog
May 16, 2025, 11:26
Antonio Giordano: Important question - which 1L CDK4/6i to preserve efficacy of re-cycling cell cycle in 2L?